Back to LL-37
LL-37 Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for LL-37.
Dosing & Reconstitution Guide
Research doses range from 1–5 μg/mL in vitro, or 1–10 mg/kg in animal models. LL-37 is not approved for use outside of the laboratory.
Standard / Gradual Approach
5mg VialstandardPhaseDoseVolume
Week 150 µg3 units (0.03 mL)
Week 2100 µg6 units (0.06 mL)
Week 3150 µg9 units (0.09 mL)
Week 4200 µg12 units (0.12 mL)
Week 5250 µg15 units (0.15 mL)
Week 6300 µg18 units (0.18 mL)
Week 7350 µg21 units (0.21 mL)
Week 8400 µg24 units (0.24 mL)
Protocol Summary
Topical: Applied once or twice daily depending on site and indication · Dose range 0.5–2 mg with gradual titration
Subcutaneous (SQ): Daily or every other day depending on inflammatory severity · Dose range 100–400 mcg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
200–400 mcg daily or every other day for 4–6 weeks. Repeat cycles as needed with immune monitoring.
Topical
Apply to affected area once or twice daily. Safe for use in infected wounds, burns, or epithelial inflammation.
🧪 Quick Start
Vial Size
5 mg
BAC Water
3 mL
Concentration
1700 mcg/unit
Starting Dose
50 µg (3 units (0.03 mL))
Maintenance Dose
400 µg (24 units (0.24 mL))
🧮 Dose Calculator
Concentration
16.7
mcg/unit
Draw Volume
30
units (0.300 mL)
For a 500 mcg dose, draw 30 units on a U-100 insulin syringe